Foundations Investment Advisors, LLC Natera, Inc. Transaction History

Foundations Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$36.57 - $58.29 $143,061 - $228,030	3,912 New	3,912 $217,000
Q3 2022 Oct 19, 2022	BUY	$36.93 - $56.68 $171,133 - $262,655	4,634 New	4,634 $203,000
Q1 2022 Apr 19, 2022	SELL	$30.32 - $91.33 $140,502 - $423,223	-4,634 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$86.26 - $119.0 $22,600 - $31,178	-262 Reduced 5.35%	4,634 $341,000
Q3 2021 Oct 13, 2021	BUY	$100.17 - $126.36 $165,681 - $208,999	1,654 Added 51.02%	4,896 $544,000
Q2 2021 Jul 14, 2021	BUY	$86.05 - $119.72 $278,974 - $388,132	3,242 New	3,242 $392,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Foundations Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundations Investment Advisors, LLC with notifications on news.